(associate) director, cmc analytical development
BaselRhyGaze AG
...validation, transfer, and lifecycle management for gene therapy products, including gene editing-, adeno-associated virus (AAV)-, and/or lipid nanoparticle (LNP)-based modalities. This individual will serve as the analytical CMC lead across external networks, ensuring scientific rigor, operational excellence, and regulatory [...]